New antiviral drug cuts cytomegalovirus infection, improves survival in patients undergoing donor stem cell transplant

In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.